Red Sox’ Chris Sale Has Flexor Strain

Red Sox ace left-hander Chris Sale has a flexor tendon strain in his left elbow, according to interim manager Ron Roenicke.

This news comes one day after Sale received a third opinion from Dr. Neil ElAttrache, after already getting a second opinion from Dr. James Andrews, in regard to the MRI of his sore left elbow.

Since his Ulnar Collateral Ligament (UCL) was “unchanged”, Sale has at least avoided surgery for the time being, as it was not recommended by either doctor. Instead, he has been prescribed rest and will not throw again for another week or so.

After that period of rest, Sale will begin throwing again and will need to be pain free while doing so. If he does still feel the same pain in his left elbow he experienced last year, then it might be time to assume the worst-case scenario.

“It sucks,” Sale said Thursday. “I know what I’m worth to this team and I don’t want to do anything stupid.”

The soon-to-be 31-year-old was already set to miss about the first two weeks of the 2020 season due to an earlier bout with pneumonia, but this setback will surely push his return date back even further depending on how things go at the end of next week.

This all comes as Sale enters the first year of the five-year, $145 million extension he signed with Boston last March. He will earn $25.6 million in 2020.

 

Red Sox’ Chris Sale Dealing With Left Elbow Soreness

Red Sox ace left-hander Chris Sale is dealing with soreness in his left elbow, according to interim manager Ron Roenicke.

Per Roenicke, Sale first experienced the soreness on Monday, one day after facing live hitters for the first time since last August. He has since been sent for an MRI and the Red Sox are awaiting the results from Dr. James Andrews.

Sale, who turns 31 later this month, was already expected to begin the 2020 season on the injured list due to an earlier bout with pneumonia that would have delayed his spring preparations, but this recent news adds another layer of concern.

In that live batting practice session on a Fenway South backfield on Sunday, Sale threw 15 pitches while utilizing his entire pitch mix, and did not feel any pain in his arm upon the session’s completion.

Heading into what is now the first year of the five-year, $145 million extension he signed with Boston last March, Sale’s left elbow has received plenty of attention over the past 12 months.

The Florida native was shut down by the Sox due to inflammation in that same elbow last August, and he received a platelet-rich plasma (PRP) injection from Dr. Andrews later that same month.

He was eventually cleared to resume throwing right around Thanksgiving, though, and up until Tuesday morning, any developments related to his left arm seemed to be positive and encouraging.

With the results of the MRI yet to be revealed, it’s unclear on where things will go from here. Worst-case scenario is most likely season-ending surgery, but we really don’t know anything yet.

What we do know is that a Red Sox starting rotation that already faced plenty of skepticism will face even more if Sale is indeed sidelined for an even longer period of time than initially anticipated.

 

Red Sox’ Chris Sale to Start 2020 Season on Injured List

Red Sox ace left-hander Chris Sale will start the 2020 season on the injured list, interim manager Ron Roenicke announced Thursday.

Sale had been recovering from a bout with pneumonia as camp broke earlier in the month, which set him back about two weeks in his preparations for the 2020 season. Because of that setback, it had already been determined that the 30-year-old would be unable to get the six spring starts the Red Sox wanted him to make before Opening Day.

Roenicke did say that the reason for Sale’s soon-to-be IL stint is completely pneumonia-related, and has nothing to do with the build-up of his arm, which is going “great.”

According to The Athletic’s Jen McCaffrey, Sale has “been throwing bullpens and has progressed to simulated games with a chance of appearing in his first game next week.”

Entering his fourth season with Boston, Sale is coming off an injury-shortened 2019 campaign where he made just 25 starts and threw 147 1/3 innings, the lowest totals of his career since he became a starter in 2012.

The Red Sox shut the lefty down in August due to inflammation in his left elbow, and he received a PRP injection from Dr. James Andrews that same month.

Another visit with Dr. Andrews in November resulted in Sale being cleared to throw with an eye towards spring training, so in terms of where he is at with his arm, everything appears fine.

Sale is set to earn $30 million in the first year of the five-year, $145 million extension he signed with the Sox last march.

As MassLive.com’s Christopher Smith notes, “IL stints for pitchers will increase from 10 days to 15 days this season.” Meaning that Sale will likely remain sidelined for the first two weeks of the 2020 campaign.

Sale’s absence to begin things means the Red Sox now have three viable starters — Eduardo Rodriguez, Nathan Eovaldi, and Martin Perez — in their rotation.

Right-hander Ryan Weber looks like an early favorite to take David Price’s spot, but who the Sox turn to to fill in for Sale will be interesting to see.

 

Red Sox Claim Right-Hander Phillips Valdez off Waivers From Mariners, Place Dustin Pedroia on 60-Day Injured List

The Red Sox have claimed right-hander Phillips Valdez off waivers from the Seattle Mariners, the club announced Sunday. In order to make room for Valdez on Boston’s 40-man roster, second baseman Dustin Pedroia was placed on the 60-day injured list.

Valdez, 28, was claimed off waivers by Seattle back in November and designated for assignment on Friday.

The Dominican Republic native spent the 2019 campaign with the Texas Rangers organization, where he made his major-league debut in June and posted an ERA of 3.94 and xFIP of 4.64 over 11 relief appearances and 16 innings of work.

While in the minors in 2019, Valdez worked as both a starter and reliever, and owned an ERA of 4.92 over 26 outings (14 starts) for the Rangers’ Triple-A club in Nashville.

An original international signee of the Indians back in 2009, Valdez’s pitch mix includes a sinker, changeup, slider, and four-seam fastball, per Statcast.

The Red Sox will be Valdez’s sixth organization, as the righty rounds out Boston’s 40-man roster for the time being.

As for Pedroia, the 36-year-old veteran suffered a setback with his surgically-repaired left knee last month and has yet to report to big-league camp.

The move to put him on the 60-day injured list is probably more of a formality than anything at this point, but it is still not great nonetheless.

As things stand right now, the Red Sox should have 67 players at major-league camp once Valdez and outfielder Cesar Puello arrive. That clubhouse is going to be crowded.

 

Red Sox’ Alex Verdugo Dealing With Stress Fracture in Lower Back

New Red Sox outfielder Alex Verdugo has a stress fracture in his lower back and his status for Opening Day is up in the air, according to interim manager Ron Roenicke.

“It takes a lot of time to heal,” Roenicke said of Verdugo’s injury earlier Saturday. “It’s an injury that’s fairly common in baseball because it’s a rotation issue. Our trainers are familiar with it. We’ll take him as the steps come — not only what the images show, but his response to things.”

One of three players acquired in the trade that sent Mookie Betts and David Price to the Dodgers earlier in the week, Verdugo missed the final two months of the 2019 season due to back and oblique issues and he himself believes it stemmed from playing on Tropicana Field’s artificial surface back in May.

The Red Sox knew of the 23-year-old’s medical history ahead of the trade’s completion, and it appears that a plan to take things slowly may already be in place.

Verdugo mentioned this plan in his first session with reporters at Fenway South on Saturday, saying that, “We have something we can draw out. The exact time frame of it, whether it’s to be ready for the start of the season or slightly after, we’re not really sure. We’re not trying to rush that. We don’t want to give people or give fans a false hope or just even a deadline we miss again.”

Because he is under team control through 2024, the Red Sox do not have any incentive to rush their new outfielder into things this year and potentially risk further injury.

“We’re going to take our time on this,” Verdugo said. “Make sure that I’m right so that way when I am playing and I’m able to be in Boston, it’s the whole year and it’s continuous that we don’t have any setbacks or anything like that.”

When healthy, the Arizona native could prove to be a tremendous asset to a new-look Red Sox outfield that also brought in ex-Blue Jays outfielder Kevin Pillar on a one-year deal on Friday.

With that added bonus of having someone like Pillar available to potentially play all three outfield positions, that proves even further why the Sox should not rush things with Verdugo.

“To be honest, if everything goes right, (Verdugo) still may not be ready for Opening Day,” Roenicke added Saturday. “We need him to be healthy to see what kind of player we have and the kind of player he knows he is.”

Full-squad workouts for the Red Sox begin on Monday, while exhibition games begin on Friday. Verdugo will presumably not see much action as he continues to rehab from his stress fracture.

Red Sox Activate Heath Hembree From Injured List

Before taking on the Tampa Bay Rays for the final time this season, the Red Sox announced that right-hander Heath Hembree has been activated from the 10-day injured list. The club made the move official earlier Monday.

Hembree had been sidelined since August 2nd, missing nearly eight weeks of action due to right elbow lateral inflammation and even receiving a plasma-rich-platelet injection for that inflammation last month.

Red Sox manager Alex Cora had been discussing over the past few days about how Hembree wanted to pitch again before seasons end, and after throwing a simulated game at Tropicana Field last week, the 30-year-old hurler is good to go for one more appearance, which could come as Boston’s opener in their series finale against the Texas Rangers on Thursday, per MassLive.com‘s Chris Cotillo.

Through 43 relief appearances this season, Hembree has posted a 4.06 ERA and .233 batting average over 37 2/3 total innings pitched. Those numbers inflated a bit when the South Carolina native returned from his first stint on the IL due to an extensor strain in his right elbow on July 4th, as he surrendered nine runs over 12 appearances and nine innings of work before hitting the injured list once again in early August.

Hembree has two more years of arbitration remaining before becoming a free agent for the first time at the conclusion of the 2021 season. He figures to be in the Sox’ bullpen plans for next year.

Red Sox Shut Down David Price for Remainder of 2019 Season

In case you missed it from earlier, the Red Sox officially shut down left-hander David Price for the remainder of the 2019 season on Wednesday.

Sox manager Alex Cora speculated that would happen when speaking with media on Tuesday, saying that, “Honestly, it feels like we’re going to shut him down. We have to go through the whole process and see how David feels about it and the medical staff. Most likely, we’ll make a final decision tomorrow.”

Per Cora, him and Price met with the club’s medical staff prior to opening up a three-game series against the San Francisco Giants on Tuesday, and less than a full day later, a final decision has been made.

The 34-year-old Price had been shelved since the beginning of the month after being scratched from his start against the New York Yankees on September 6th.

“We’re going to see what’s going on with his cyst and actually check his wrist,” said Cora on Wednesday. “If there’s something else, we’ll take care of that. If there’s something going on. I think it’s a head start to next year. It’s a smart thing to do.”

In 22 starts this season, Price posted an ERA of 4.28 and batting average against of .258 over 107 1/3 innings pitched. The Red Sox went 10-12 in those games.

Those numbers regressed coming out of the All-Star break, possibly highlighting when the Tennessee native’s left wrist became more of a pressing issue.

Price did receive a cortisone shot to try and remove a TFCC cyst from that left wrist back on August 8th, but was only able to make one start following that procedure, which came on September 1st when he tosses two scoreless innings against the Los Angeles Angels.

Speaking of procedures, Cora also said Wednesday that, “Whenever [the doctors] decide if they have to do that (a procedure), they’ll probably do it before the season ends,” Something to keep an eye out for.

Red Sox’ Chris Sale Receives PRP Injection, Will Be Re-Evaluated in Six Weeks

After it was revealed that left-hander Chris Sale would not need Tommy John Surgery, the Red Sox announced that the 30-year-old received a platelet-rich plasma injection during his visit with Dr. James Andrews on Monday.

Dr. Andrews confirmed that Sale did indeed have inflammation in his throwing elbow prior to the injection, and recommended a shutdown period of six weeks before being re-evaluated once more.

Here’s the official statement from Red Sox president of baseball operations Dave Dombrowski.

As you may have already figured out, six weeks from now is September 30th, meaning that Sale’s 2019 season is likely over. Dombrowski confirmed that himself, per MLB.com’s Ian Browne.

If that is indeed the case, the Florida native’s third year with Boston was rather underwhelming.

In 25 starts, Sale posted a 4.40 ERA and .221 batting average against over 147 1/3 innings pitched, presumably ending his run of seven straight seasons finishing in the top seven for American League Cy Young Award voting. The Red Sox went 10-15 in those games.

As mentioned earlier, Sale will be re-evaluated by Dr. Andrews in late September. For now, the Red Sox need to find someone to take their ace’s spot in the starting rotation.

Red Sox’ Chris Sale Does Not Need Tommy John Surgery, per Report

Red Sox left-hander Chris Sale does NOT need to undergo Tommy John surgery, according to ESPN’s Jeff Passan.

Sale, 30, was placed on the 10-day injured list this past Saturday due to left elbow inflammation. The move was retroactive to August 14th.

Along with Sox head athletic trainer Brad Pearson, Sale traveled to Pensacola, Fla. on Monday to receive a second opinion on his elbow from Dr. James Andrews after undergoing an MRI on Saturday.

When Dr. Andrews’ name is brought up in these scenarios, bad news usually ensues, but this time around, the knee, elbow, and shoulder specialist confirmed the initial diagnosis of inflammation in Sale’s throwing elbow.

Through 25 starts this season, Sale has posted an ERA of 4.40 and batting average against of .221 to go along with 218 strikeouts over 147 1/3 innings pitched. That includes an outing in which he punched out 12 to surpass the 2,000 mark for his career in his last time out before hitting the IL against the Cleveland Indians on Tuesday.

According to MassLive.com’s Christopher Smith, an official statement from the Red Sox pertaining to Monday’s events will be released shortly, so stay tuned for that.

Red Sox Place Chris Sale on Injured List Due to Left Elbow Inflammation

In case you missed it, the Red Sox announced that left-hander Chris Sale had been placed on the 10-day injured list due to left elbow inflammation prior to Saturday’s win over the Baltimore Orioles.

In a corresponding move, right-hander Ryan Brasier was recalled from Triple-A Pawtucket. The club made the transaction official earlier on Saturday.

Sale allowed five runs, three of which were earned, on five hits, two walks, and 12 strikeouts over 6 2/3 innings in his last time out against the Cleveland Indians this past Tuesday.

According to Red Sox president of baseball operations Dave Dombrowski, the 30-year-old felt stiffness in his left elbow in the two days following his last start and informed the team’s training staff of it on Friday, which ultimately led to an MRI on Saturday.

“We’re not taking any chances and putting him on the injured list,” Dombrowski said when speaking with reporters Saturday. “There’s going to be further evaluation. Our doctors looked at the MRI. We’ll have other doctors look at the MRI. We’re in a situation where I don’t really know where it’s going to take us at this point. People will further read the MRIs, and then they’ll make their diagnosis.”

One of those other opinions will come from Dr. James Andrews, who will more than likely meet with Sale as well.

Sale himself was not made available to the media on Saturday. As Dombrowski put it, “Chris, I think, needs a couple of days to himself at this point.”

Obviously, there’s no timetable for when Sale could possibly make any kind of return. In fact, when asked about whether or not the Florida native will pitch again in 2019, all Dombrowski could say was, “I don’t know one way or another at this point.”

Sale was scheduled to start against the Philadelphia Phillies on Tuesday. A replacement has yet to be named by Sox manager Alex Cora, who said that, “Somebody has to step up. That’s how it works in this business,” following Saturday’s win over the Orioles.

On the other side of this move, Ryan Brasier was recalled from Pawtucket one month after a somewhat-surprising demotion.

In that time with the PawSox, the 31-year-old posted a 0.96 ERA and .182 batting average against over 10 relief appearances and 9 1/3 innings pitched.

On the 2019 campaign as a whole, Brasier owns an ERA of 4.46 and batting average against of .242 in 44 appearances and 40 1/3 innings of work with Boston. He did not pitch Saturday.

Stay tuned for something on here if Sale speaks with the media in the next few days.